Financials Ningbo Sanxing Medical Electric Co.,Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
35.22 ^CNY	+0.80%		+4.51%	+71.80%

Apr. 25	Ningbo Sanxing Medical Electric Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Ningbo Sanxing Medical Electric Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	9,221	22,615	18,980	28,947	49,702	-	-
Enterprise Value (EV) ¹	9,221	22,615	18,980	28,947	49,702	49,702	49,702
P/E ratio	9.64 x	32.6 x	20.1 x	15.2 x	21.5 x	18.1 x	14.3 x
Yield	-	-	-	3.17%	2.27%	2.74%	3.49%
Capitalization / Revenue	-	3.22 x	2.09 x	2.53 x	3.52 x	2.96 x	2.6 x
EV / Revenue	-	3.22 x	2.09 x	2.53 x	3.52 x	2.96 x	2.6 x
EV / EBITDA	-	21.2 x	13.4 x	11.2 x	14.4 x	13.2 x	-
EV / FCF	-	-	-	21.5 x	45.9 x	22 x	17 x
FCF Yield	-	-	-	4.66%	2.18%	4.54%	5.87%
Price to Book	-	2.55 x	2 x	2.63 x	3.99 x	3.44 x	3.06 x
Nbr of stocks (in thousands)	1,386,569	1,386,569	1,407,977	1,412,070	1,411,197	-	-
Reference price ²	6.650	16.31	13.48	20.50	35.22	35.22	35.22
Announcement Date	4/19/21	4/25/22	4/26/23	4/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	7,023	9,098	11,463	14,115	16,804	19,152
EBITDA ¹	-	1,068	1,415	2,578	3,444	3,752	-
EBIT ¹	-	851.2	1,152	2,270	2,743	3,311	4,150
Operating Margin	-	12.12%	12.67%	19.81%	19.43%	19.7%	21.67%
Earnings before Tax (EBT) ¹	-	846.8	1,152	2,262	2,744	3,312	4,152
Net income ¹	956.1	690	948.1	1,904	2,306	2,744	3,481
Net margin	-	9.83%	10.42%	16.61%	16.33%	16.33%	18.18%
EPS ²	0.6900	0.5000	0.6700	1.350	1.635	1.942	2.470
Free Cash Flow ¹	-	-	-	1,348	1,082	2,256	2,916
FCF margin	-	-	-	11.76%	7.67%	13.42%	15.23%
FCF Conversion (EBITDA)	-	-	-	52.3%	31.42%	60.12%	-
FCF Conversion (Net income)	-	-	-	70.82%	46.93%	82.21%	83.77%
Dividend per Share ²	-	-	-	0.6500	0.8000	0.9633	1.230
Announcement Date	4/19/21	4/25/22	4/26/23	4/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-
Free Cash Flow ¹	-	-	-	1,348	1,082	2,256	2,916
ROE (net income / shareholders' equity)	-	7.9%	10.3%	18.5%	19.8%	19.7%	23.2%
ROA (Net income/ Total Assets)	-	-	-	-	10.1%	11.1%	-
Assets ¹	-	-	-	-	22,827	24,730	-
Book Value Per Share ²	-	6.400	6.750	7.790	8.820	10.20	11.50
Cash Flow per Share ²	-	0.1400	0.8700	1.350	1.980	2.190	-
Capex ¹	-	294	404	553	450	392	50
Capex / Sales	-	4.19%	4.44%	4.83%	3.19%	2.33%	0.26%
Announcement Date	4/19/21	4/25/22	4/26/23	4/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

35.22 CNY

Average target price

35.25 CNY

Spread / Average Target

+0.09%

	1st Jan change	Capi.
NINGBO SANXING MEDICAL ELECTRIC CO.,LTD.	+71.80%	6.88B
ZHONGHANG ELECTRONIC MEASURING INSTRUMENTS CO.,LTD	-2.35%	3.47B
CHROMA ATE INC.	+19.01%	3.31B
HEFEI MEYER OPTOELECTRONIC TECHNOLOGY INC.	-8.50%	2.19B
LEM HOLDING SA	-21.73%	2.04B
JIANGSU LINYANG ENERGY CO., LTD.	+8.45%	1.96B
KELI SENSING TECHNOLOGY (NINGBO) CO.,LTD.	-21.70%	1.1B
HANGZHOU SUNRISE TECHNOLOGY CO.,LTD.	+14.06%	1.1B
CHANGCHUN UP OPTOTECH CO.,LTD.	-17.00%	928M
WASION HOLDINGS LIMITED	+72.96%	864M